Menopause
Conference Coverage
Ospemifene’s effect more comprehensive than its FDA indication
Key clinical point: Ospemifene could be an effective treatment for a range of moderate to severe menopausal symptoms. Major finding: Ospemifine 60...
News
Try testosterone only in women with hypoactive sexual desire
News
Soy isoflavones safe in postmenopausal women, data from 3-year trial showed
Key clinical point: Soy isoflavones taken long term can be an effective nonpharmacogenic treatment of postmenopausal symptoms. Major finding:...
Arnold Advincula's Surgical Techniques
The Extracorporeal C-Incision Tissue Extraction (ExCITE) technique
Conference Coverage
VIDEO: SERMs move beyond osteoporosis, breast cancer prevention
Conference Coverage
Ovarian aging may be tip-off for cardiovascular risk
Key clinical point: “Older” ovaries were associated with increased cardiovascular risk. Major finding: The 10-year risk of MI was 2.1% in women in...
Conference Coverage
Purified pollen extract for hot flashes did not inhibit tamoxifen’s efficacy
Key clinical point: When SSRIs are contraindicated for treatment of vasomotor symptoms, such as in women taking tamoxifen, Relizen was found to be...
Expert Commentary
Female sexual dysfunction: Is pharmacologic treatment a future reality or just wishful thinking?
Jan Shifren, MD, discusses in which patients pharmacologic treatment is appropriate, which pharmacologic treatments are actual management options...
Video
VIDEO: Novel and other therapies for vaginal dryness
Conference Coverage
VIDEO: Causes of low libido in postmenopausal women are complex, don’t always require pharmacologic treatment
Expert Commentary
MenoPro: An app from NAMS for you and your menopausal patient
What are your patient’s cardiovascular and breast cancer risks and her best options for menopausal symptom treatment? A free app to aid you in...